Indacaterol/glicopirronio frente a Tiotropio/formoterol en EPOC moderada-grave : Estudio QUANTIFY

http://thorax.bmj.com/content/early/2015/02/12/thoraxjnl-2014-206345.full.pdf+html

Conclusions:
Indacaterol/glycopyrronium is non-inferior to TIO+FOR in improving HRQoL, with clinically meaningful and significant improvements in breathlessness and lung function in patients with COPD.